Epigenetic: A molecular link between testicular cancer and environmental exposures

Frontiers in Endocrinology

Volumn 3, Issue NOV, 2012, Pages

  Vega, Aurelie ^a,b,c,d   Baptissart, Marine ^a,b,c,d   Caira, Françoise ^a,b,c,d   Brugnon, Florence ^a,b,c,d   Lobaccaro, Jean Marc A ^a,b,c,d   Volle, David H ^a,b,c,d  

^a Faculté de Médecine   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CNRS   (France)

^d CRNH AUVERGNE   (France)

Author keywords

Endocrine disrupters; Epigenetic; Physiology; Testicular cancer

Indexed keywords

EID: 84874375382     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00150     Document Type: Review

References (147)

1. Adham, I. M., and Agoulnik, A. I. (2004). Insulin-like 3 signalling in testicular descent. Int. J. Androl. 27, 257-265.
2. Adiga, S. K., Ehmcke, J., Schlatt, S., Kliesch, S., Westernströer, B., Luetjens, C. M., et al. (2011). Reduced expression of DNMT3B in the germ cells of patients with bilateral spermatogenic arrest does not lead to changes in the global methylation status. Mol Hum. Reprod. 17, 545-549.
3. Alagaratnam, S., Lind, G. E., Kraggerud, S. M., Lothe, R. A., and Skotheim, R. I. (2011). The testicular germ cell tumour transcriptome. Int. J. Androl. 34(Pt2), e133-e150.
4. Almstrup, K., Nielsen, J. E., Mlynarska, O., Jansen, M. T., Jørgensen, A., Skakkebæk, N. E., et al. (2010). Carcinoma in situ testis displays permissive chromatin modifications similar to immature foet al germ cells. Br. J. Cancer 103, 1269-1276.
5. Anway, M. D., Cupp, A. S., Uzumcu, M., and Skinner, M. K. (2005). Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308, 1466-1469.
6. Arai, E., Nakagawa, T., Wakai-Ushijima, S., Fujimoto, H., andKanai, Y. (2012). DNA methyltransferase 3B expression is associated with poor outcome of stage I testicular seminoma. Histopathology 60, E12-E18.
7. Aschim, E. L., Haugen, T. B., Tretli, S., Daltveit, A. K., and Grotmol, T. (2006). Risk factors for testicular cancer-differences between pure non-seminoma and mixed seminoma/non-seminoma? Int. J. Androl. 29, 458-467.
8. Aschim, E. L., Giwercman, A., Ståhl, O., Eberhard, J., Cwikiel, M., et al. (2005). The RsaI polymorphism in the estrogen receptor-beta gene is associated with male infertility. J. Clin. Endocrinol Metab. 90, 5343-5348.
9. Atkin, N. B., and Baker, M. C. (1982). Specific chromosome change, i(12p), in testicular tumours? Lancet2, 1349.
10. Bao, J., Li, D., Wang, L., Wu, J., Hu, Y., Wang, Z., et al. (2012). MicroRNA-449 and microRNA-34b/c function redundantly in murine testes by targeting E2F transcription factor-retinoblastoma protein (E2F-pRb) pathway. J. Biol Chem. 287, 21686-21698.
11. Biggs, M. L., Davis, M. D., Eaton, D. L., Weiss, N. S., Barr, D. B., Doody, D. R., et al. (2008). Serum organochlorine pesticide residues and risk of testicular germ cell carcinoma: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 17, 2012-2018.
12. Boisen, K. A., Main, K. M., Rajpert-De Meyts, E., and Skakkebaek, N. E. (2001). Are male reproductive disorders a common entity? The testicular dysgenesis syndrome. Ann. N. Y. Acad. Sci. 948, 90-99.
13. Bowles, J., Knight, D., Smith, C., Wilhelm, D., Richman, J., Mamiya, S., et al. (2006). Retinoid signaling determines germ cell fate in mice. Science 312, 596-600.
14. Brait, M., Maldonado, L., Begum, S., Loyo, M., Wehle, D., Tavora, E E, et al. (2012). DNA methylation profiles delineate epigenetic heterogene-ity in seminomaand non-seminoma. Br.J. Cancer 106, 414-423.
15. Brokken, L. J. S., Lundberg-Giwercman, Y., De-Meyts, E. R., Eberhard, J., Ståhl, O., Cohn-Cedermark, G., et al. (2012). Association of polymorphisms in genes encoding hormone receptors ESR1, ESR2 and LHCGR with the risk and clinical features of testicular germ cell cancer. Mol. Cell. Endocrinol. 351, 279-285.
16. Brunereau, L., Bruyère, F., Linassier, C., and Baulieu, J.-L. (2012). The role of imaging in staging and monitoring testicular cancer. Diagn. Interv. Imaging 93, 310-318.
17. Buckley, B. A., Burkhart, K. B., Gu, S. G., Spracklin, G., Kershner, A., Fritz, H., et al. (2012). A nuclear Argonaute promotes multigenerational epigenetic inheritance and germline immortality. Nature 489, 447-451.
18. Bullock, B. C., Newbold, R. R., and McLachlan, J. A. (1988). Lesions of testis and epididymis associated with prenatal diethylstilbestrol exposure. Environ. Health Perspect. 77, 29-31.
19. Burns, W. R., Sabanegh, E., Dada, R., Rein, B., and Agarwal, A. (2010). Is male infertility a forerunner to cancer? Int. Braz. J. Urol. 36, 527-536.
20. Carreau, S., and Hess, R. A. (2010). Oestrogens and spermatogenesis. Philos. Trans. R. Soc. Lond. B Biol. Sci. 365, 1517-1535.
21. Cederroth, C. R., Schaad, O., Descombes, P., Chambon, P., Vassalli, J.-D., and Nef, S. (2007). Estrogen receptor alpha is a major contributor to estrogen-mediated fet al testis dysgenesis and cryptorchidism. Endocrinology 148, 5507-5519.
22. Chang, C.-J., and Hung, M.-C. (2012). The role of EZH2 in tumour progression. Br. J. Cancer 106, 243-247.
23. Cheng, C. Y., and Mruk, D. D. (2012). The blood-testis barrier and its implications for male contraception. Pharmacol. Rev. 64, 16-64.
24. Cheung, H.-H., Davis, A. J., Lee, T.-L., Pang, A. L., Nagrani, S., Rennert, O. M., et al. (2011). Methylation of an intronic region regulates miR-199a in testicular tumor malignancy. Oncogene 30, 3404-3415.
25. Chia, V. M., Li, Y., Quraishi, S. M., Graubard, B. I., Figueroa, J. D., Weber, J.-P., et al. (2010). Effect modification of endocrine disruptors and testicular germ cell tumour risk by hormone-metabolizing genes. Int. J. Androl. 33, 588-596.
26. Clark, A. T., Rodriguez, R. T., Bodnar, M. S., Abeyta, M. J., Cedars, M. I., Turek, P. J., et al. (2004). Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. Stem Cells 22, 169-179.
27. Couse, I. E, and Korach, K. S. (1999). Estrogen receptor null mice: what have we learned and where will they lead us. Endocr. Rev. 20, 358-417.
28. Davis-Dao, C. A., Siegmund, K. D., Vandenberg, D. J., Skinner, E. C., Coetzee, G. A., Thomas, D. C., et al. (2011). Heterogenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: shorter repeats associated with seminoma but not other histologic types. Carcinogenesis 32, 1238-1243.
29. De Jong, J., Weeda, S., Gillis, A. J. M., Oosterhuis, J. W., and Looijenga, L. H. J. (2007). Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors. Oncol. Rep. 18, 127-132.
30. Desdoits-Lethimonier, C., Albert, O., Le Bizec, B., Perdu, E., Zalko, D., Courant, F., et al. (2012). Human testis steroidogenesis is inhibited by phthalates. Hum. Reprod. 27, 1451-1459.
31. Dhar, S., Thota, A., and Rao, M. R. S. (2012). Insights into role of bromod-omain, testis-specific (Brdt) in acetylated histone H4-dependent chromatin remodeling in mammalian spermiogenesis. J. Biol. Chem. 287, 6387-6405.
32. Eckert, D., Biermann, K., Nettersheim, D., Gillis, A. J. M., Steger, K., Jäck, H.-M., et al. (2008). Expression of BLIMP 1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fet al germ cells, CIS/IGCNU and germ cell tumors. BMC Dev. Biol. 8, 106. doi: 10.1186/1471-213X-8-106
33. Eddy, E. M., Washburn, T. F., Bunch, D. O., Goulding, E. H., Gladen, B. C., Lubahn, D. B., et al. (1996). Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 137, 4796-4805.
34. Ellinger, J., Albers, P., Perabo, E G., Müller, S. C., von Ruecker, A., and Bastian, P. J. (2009). CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. J. Urol. 182, 324-329.
35. Fenic, I., Hossain, H. M., Sonnack, V., Tchatalbachev, S., Thierer, F., Trapp, J., et al. (2008). In vivo application of histone deacetylase inhibitor trichostatina impairs murine male meiosis. J. Androl. 29, 172-185.
36. Ferlin, A., Bogatcheva, N. V., Gianesello, L., Pepe, A., Vinanzi, C., Agoulnik, A. I., et al. (2006). Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization. Mol. Hum. Reprod. 12, 401-406.
37. Ferlin, A., Ganz, F., Pengo, M., Selice, R., Frigo, A. C., and Foresta, C. (2010). Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes. Endocr. Relat. Cancer 17, 17-25.
38. Ferlin, A., Zuccarello, D., Garolla, A., Selice, R., Vinanzi, C., Ganz, F., et al. (2009). Mutations in INSL3 and RXFP2 genes in cryptorchid boys. Ann. N. Y. Acad. Sci. 1160, 213-214.
39. Figueroa, J. D., Sakoda, L. C., Graubard, B. I., Chanock, S., Rubertone, M. V., Erickson, R. L., et al. (2008). Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors. Cancer Causes Control 19, 917-929.
40. Fritzsche, E R., Hasler, A., Bode, P. K., Adams, H., Seifert, H. H., Sulser, T., et al. (2011). Expression of histone deacetylases 1, 2 and 3 in histo-logical subtypes of testicular germ cell tumours. Histol. Histopathol. 26, 1555-1561.
41. Garolla, A., Ferlin, A., Vinanzi, C., Roverato, A., Sotti, G., Artibani, W., et al. (2005). Molecular analysis of the androgen receptor gene in testicular cancer. Endocr. Relat. Cancer 12, 645-655.
42. Giannandrea, F., Gandini, L., Paoli, D., Turci, R., and Figà-Talamanca, I. (2011). Pesticide exposure and serum organochlorine residuals among testicular cancer patients and healthy controls. J. Environ. Sci. Health B 46, 780-787.
43. Godmann, M., Lambrot, R., and Kimmins, S. (2009). The dynamic epigenetic program in male germ cells: its role in spermatogenesis, testis cancer, and its response to the environment. Microsc. Res. Tech. 72, 603-619.
44. Greene, M. H., Kratz, C. P., Mai, P. L., Mueller, C., Peters, J. A., Bratslavsky, G., et al. (2010). Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocr. Relat. Cancer 17, R109-R121.
45. Gryder, B. E., Sodji, Q. H., and Oyelere, A. K. (2012). Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Future Med. Chem. 4, 505-524.
46. Gu, Y., Runyan, C., Shoemaker, A., Surani, A., andWylie, C. (2009). Steel factor controls primordial germ cell survival and motility from the time of their specification in the allantois, and provides a continuous niche throughout their migration. Development 136, 1295-1303.
47. Hardell, L., Bavel, B., Lindström, G., Eriksson, M., and Carlberg, M. (2006). In utero exposure to persistent organic pollutants in relation to testicular cancer risk. Int. J. Androl. 29, 228-234.
48. Hardell, L., Malmqvist, N., Ohlson, C.-G., Westberg, H., and Eriksson, M. (2004). Testicular cancer and occupational exposure to polyvinyl chloride plastics: a case-control study. Int. J. Cancer 109, 425-429.
49. Hardell, L., van Bavel, B., Lindström, G., Carlberg, M., Eriksson, M., Dreifaldt, A. C., et al. (2004). Concentrations ofpolychlorinatedbiphenylsinblood and the risk for testicular cancer. Int. J. Androl. 27, 282-290.
50. Hardell, L., van Bavel, B., Lindström, G., Carlberg, M., Dreifaldt, A. C., Wijkström, H., et al. (2003). Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. Environ. Health Perspect. 111, 930-934.
51. He, Z., Kokkinaki, M., Pant, D., Gallicano, G. I., and Dym, M. (2009). Small RNA molecules in the regulation of spermatogenesis. Reproduction 137, 901-911.
52. Hess, R. A., Bunick, D., Lee, K. H., Bahr, J., Taylor, J. A., Korach, K. S., and Lubahn, D. B. (1997). A role for oestrogens in the male reproductive system. Nature 390, 509-512.
53. Hines, E. P., Calafat, A. M., Silva, M. J., Mendola, P., andFenton, S. E. (2009). Concentrations of phthalate metabolites in milk, urine, saliva, and serum of lactating North Carolina women. Environ. Health Perspect. 117, 86-92.
54. Hinz, S., Magheli, A., Weikert, S., Schulze, W., Krause, H., Schrader, M., et al. (2010). Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors. WorldJ. Urol. 28, 631-635.
55. Huang, L., Huang, R., Ran, X.-R., Liu, H.-Y., Zhang, Y., Dai, L.-J., et al. (2011). Three-generation experiment showed female C57BL/6J mice drink drainage canal water containing low level of TCDD-like activity causing high pup mortality. J. Toxicol. Sci. 36, 713-724.
56. Iguchi, T., Watanabe, H., and Katsu, Y (2001). Developmental effects of estrogenic agents on mice, fish, and frogs: a mini-review. Horm. Behav. 40, 248-251.
57. Ivell, R., and Anand-Ivell, R. (2011). Biological role and clinical significance of insulin-like peptide 3. Curr. Opin. Endocrinol Diabetes Obes. 18, 210-216.
58. Jacobsen, G. K., and Henriques, U. V. (1992). A fet al testis with intratubular germ cell neoplasia (ITGCN). Mod. Pathol. 5, 547-549.
59. Jégou, B. (1993). The Sertoligerm cell communication network in mammals. Int. Rev. Cytol. 147, 25-96.
60. Joensen, U. N., Jørgensen, N., Rajpert-De Meyts, E., and Skakkebaek, N. E. (2008). Testicular dysgenesis syndrome and Leydig cell function. Basic Clin. Pharmacol. Toxicol. 102, 155-161.
61. Johnson, L., Wilker, C. E., Safe, S. H., Scott, B., Dean, D. D., and White, P. H. (1994). 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin reduces the number, size, and organelle content of Leydig cells in adult rat testes. Toxicology 89, 49-65.
62. Kaleva, M., and Toppari, J. (2005). Cryptorchidism: an indicator of testicular dysgenesis? Cell Tissue Res. 322, 167-172.
63. Kanetsky, P. A., Mitra, N., Vardhanabhuti, S., Li, M., Vaughn, D. J., Letrero, R., et al. (2009). Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat. Genet. 41, 811-815.
64. Kibanov, M. V., Gvozdev, V. A., and Olenina, L. V. (2012). Germ granules in spermatogenesis of Drosophila: evidences of contribution to the piRNA silencing. Commun. Integr. Biol. 5, 130-133.
65. Kleeman, J. M., Moore, R. W., and Peterson, R. E. (1990). Inhibition of testicular steroidogenesis in 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-treated rats: evidence that the key lesion occurs prior to or during pregnenolone formation. Toxicol. Appl. Pharmacol. 106, 112-125.
66. Korhonen, H. M., Meikar, O., Yadav, R. P., Papaioannou, M. D., Romero, Y., Da Ros, M., et al. (2011). Dicer is required for haploid male germ cell differentiation in mice. PLoS ONE 6, e24821. doi: 10.1371/journal.pone.0024821
67. Koster, R., di Pietro, A., Timmer-Bosscha, H., Gibcus, J. H., van den Berg, A., Suurmeijer, A. J., et al. (2010). Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer. J. Clin. Invest. 120, 3594-3605.
68. Koubova, J., Menke, D. B., Zhou, Q., Capel, B., Griswold, M. D., and Page, D. C. (2006). Retinoic acid regulates sex-specific timing of meiotic initiation in mice. Proc. Natl. Acad. Sci. U.S.A. 103, 2474-2479.
69. Koychev, D., Oechsle, K., Bokemeyer, C., and Honecker, F. (2011). Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update. Int. J. Androl. 34(Pt2), e266-273.
70. Kristiansen, W., Aschim, E. L., Andersen, J. M., Witczak, O., Fosså, S. D., and Haugen, T. B. (2012). Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men. Int. J. Androl. doi: 10.1111/j.1365-2605.2012.01297.x [Epub ahead of print].
71. Kristiansen, W., Haugen, T. B., Witczak, O., Andersen, J. M., Fosså, S. D., and Aschim, E. L. (2011). CYP1A1, CYP3A5andCYP3A7polymorphisms and testicular cancer susceptibility. Int. J. Androl. 34, 77-83.
72. Lai, K. P., Wong, M. H., and Wong, C. K. C. (2005). Inhibition of CYP450scc expression in dioxin-exposed rat Leydig cells.J. Endocrinol. 185, 519-527.
73. Lambrot, R., Jones, S., Saint-Phar, S., and Kimmins, S. (2012). Specialized distribution of the histone methyl-transferase ezh2 in the nuclear apical region of round spermatids and its interaction with the histone variant h1t2. J. Androl. 33, 1058-1066.
74. Lambrot, R., and Kimmins, S. (2011). Histone methylation is a critical regulator of the abnormal expression of POU5F1 and RASSF1A in testis cancer cell lines. Int. J. Androl. 34, 110-123.
75. La Salle, S., Oakes, C. C., Neaga, O. R., Bourc'his, D., Bestor, T. H., and Trasler, J. M. (2007). Loss of sper-matogonia and wide-spread DNA methylation defects in newborn male mice deficient in DNMT3L. BMC Dev. Biol. 7, 104. doi: 10.1186/1471-213X-7-104
76. Cyp26b1 expression in murine Sertoli cells is required to maintain male germ cells in an undifferentiated state during embryogenesis
77. Lian, J., Zhang, X., Tian, H., Liang, N., Wang, Y., Liang, C., et al. (2009). Altered microRNA expression in patients with non-obstructive azoospermia. Reprod. Biol. Endocrinol. 7, 13.
78. Lubahn, D. B., Moyer, J. S., Golding, T. S., Couse, J. F., Korach, K. S., and Smithies, O. (1993). Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U.S.A. 90, 11162-11166.
79. Mannuel, H. D., Mitikiri, N., Khan, M., and Hussain, A. (2012). Testicular germ cell tumors: biology and clinical update. Curr. Opin. Oncol. 24, 266-271.
80. Manton, K. J., Douglas, M. L., Netzel-Arnett, S., Fitzpatrick, D. R., Nicol, D. L., Boyd, A. W., et al. (2005). Hyper-methylation of the 5' CpG island of the gene encoding the serine protease testisin promotes its loss in testicular tumorigenesis. Br. J. Cancer 92, 760-769.
81. Maselli, J., Hales, B. F., Chan, P., and Robaire, B. (2012). Exposure to bleomycin, etoposide, and cis-platinum alters rat sperm chromatin integrity and sperm head protein profile. Biol. Reprod. 86, 166, 1-10.
82. McGlynn, K. A., Quraishi, S. M., Graubard, B. I., Weber, J.-P., Ruber-tone, M. V., and Erickson, R. L. (2009). Polychlorinated biphenyls and risk of testicular germ cell tumors. Cancer Res. 69, 1901-1909.
83. Minami, K., Chano, T., Kawakami, T., Ushida, H., Kushima, R., Okabe, H., et al. (2010). DNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma. Clin. Cancer Res. 16, 2751-2759.
84. Moore, R. W., Jefcoate, C. R., and Peterson, R. E. (1991). 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin inhibits steroidogenesis in the rat testis by inhibiting the mobilization of cholesterol to cytochrome P450scc. Toxicol. Appl. Pharmacol. 109, 85-97.
85. Naciff, J. M., and Daston, G. P. (2004). Toxicogenomic approach to endocrine disrupters: identification of a transcript profile characteristic of chemicals with estrogenic activity. Toxicol. Pathol. 32(Suppl. 2), 59-70.
86. Nagahama, Y., Nakamura, M., Kitano, T., and Tokumoto, T. (2004). Sexual plasticity in fish: a possible target of endocrine disruptor action. Environ. Sci. 11, 73-82.
87. Nettersheim, D., Biermann, K., Gillis, A. J. M., Steger, K., Looijenga, L. H. J., and Schorle, H. (2011). NANOG promoter methylation and expression correlation during normal and malignant human germ cell development. Epigenetics 6, 114-122.
88. Niu, Z., Goodyear, S. M., Rao, S., Wu, X., Tobias, J. W., Avarbock, M. R., et al. (2011). MicroRNA-21 regulates the self-renewal of mouse spermato-gonial stem cells. Proc. Natl. Acad. Sci. U.S.A. 108, 12740-12745.
89. Novotny, G. W., Belling, K. C., Bramsen, J. B., Nielsen, J. E., Bork-Jensen, J., Almstrup, K., et al. (2012). MicroRNA expression profiling of carcinoma in situ cells of the testis. Endocr. Relat. Cancer 19, 365-379.
90. O'Carroll, D., Scherthan, H., Peters, A. H., Opravil, S., Haynes, A. R., Laible, G., et al. (2000). Isolation and characterization of Suv39h2, asecond histone H3 methyltransferase gene that displays testis-specific expression. Mol Cell. Biol. 20, 9423-9433.
91. Ohlson, C. G., and Hardell, L. (2000). Testicular cancer and occupational exposures with a focus on xenoestrogens in polyvinyl chloride plastics. Chemosphere 40, 1277-1282.
92. Okamoto, K., and Kawakami, T. (2007). Epigenetic profile of testicular germ cell tumours. Int. J. Androl. 30, 385-392.
93. Olesen, I. A., Sonne, S. B., Hoei-Hansen, C. E., Rajpert-DeMeyts, E., and Skakkebaek, N. E. (2007). Environment, testicular dysgenesis and carcinoma in situ testis. Best Pract. Res. Clin. Endocrinol. Metab. 21, 462-478.
94. Omisanjo, O. A., Biermann, K., Hartmann, S., Heukamp, L. C., Sonnack, V., Hild, A., et al. (2007). DNMT1 and HDAC1 gene expression in impaired spermatogenesis and testicular cancer. Histochem. Cell Biol. 127, 175-181.
95. Papaioannou, M. D., and Nef, S. (2010). microRNAs in the testis: building up male fertility. J. Androl. 31, 26-33.
96. Pentikäinen, V., Erkkilä, K., Suomalainen, L., Parvinen, M., and Dunkel, L. (2000). Estradiol acts as a germ cell survival factor in the human testis in vitro. J. Clin. Endocrinol. Metab. 85, 2057-2067.
97. Peters, A. H., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., et al. (2001). Loss of the Suv39h histone methyl-transferases impairs mammalian het-erochromatin and genome stability. Cell 107, 323-337.
98. Purdue, M. P., Engel, L. S., Langseth, H., Needham, L. L., Andersen, A., Barr, D. B., et al. (2009). Prediagnostic serum concentrations of organochlorine compounds and risk of testicular germ cell tumors. Environ. Health Perspect. 117, 1514-1519.
99. Rajpert-De Meyts, E., Leffers, H., Daugaard, G., Andersen, C. B., Petersen, P. M., Hinrichsen, J., et al. (2002). Analysis of the polymorphic CAG repeat length in the androgen receptor gene in patients with testicular germ cell cancer. Intl. J. Cancer 102, 201-204.
100. Richardson, L. C., Neri, A. J., Tai, E., and Glenn, J. D. (2012). Testicular cancer: a narrative review of the role of socioeconomic position from risk to survivorship. Urol. Oncol. 30, 95-101.
101. Richiardi, L., Bellocco, R., Adami, H.-O., Torrång, A., Barlow, L., Hakulinen, T., et al. (2004). Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol. Biomarkers Prev. 13, 2157-2166.
102. Robertson, K. M., O'Donnell, L., Jones, M. E., Meachem, S. J., Boon, W. C., Fisher, C. R., et al. (1999). Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc. Natl. Acad. Sci. U.S.A. 96, 7986-7991.
103. Rodriguez, S., Jafer, O., Goker, H., Summersgill, B. M., Zafarana, G., Gillis, A. J. M., et al. (2003). Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. Oncogene 22, 1880-1891.
104. Romerius, P., Giwercman, A., Moëll, C., Relander, T., Cavallin-Ståhl, E., Wiebe, T., et al. (2011). Estrogen receptor α single nucleotide polymorphism modifies the risk of azoospermiain childhood cancer survivors. Pharmacogenet. Genomics 21, 263-269.
105. Rubin, B. S. (2011). Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J. Steroid Biochem. Mol. Biol. 127, 27-34.
106. Sasaki, A., Taketomi, T., Kato, R., Saeki, K., Nonami, A., Sasaki, M., et al. (2003). Mammalian Sprouty4 suppresses Rasindependent ERK activation by binding to Raf1. Nat. Cell Biol. 5, 427-432.
107. Schoevers, E. J., Santos, R. R., Colenbrander, B., Fink-Gremmels, J., and Roelen, B. A. J. (2012). Transgenerational toxicity of Zearalenone in pigs. Reprod. Toxicol. 34, 110-119.
108. Schotta, G., Ebert, A., and Reuter, G. (2003). SU(VAR)3-9 is a conserved key function in heterochromatic gene silencing. Genetica 117, 149-158.
109. Sharpe, R. M., and Skakkebaek, N. E. (1993). Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341, 1392-1395.
110. Sikka, S. C., and Wang, R. (2008). Endocrine disruptors and estrogenic effects on male reproductive axis. Asian J. Androl. 10, 134-145.
111. Skakkebaek, N. E., Rajpert-De Meyts, E., and Main, K. M. (2001). Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16, 972-978.
112. Skinner, M. K., Norton, J. N., Mullaney, B. P., Rosselli, M., Whaley, P. D., and Anthony, C.T. (1991). Cell-cell interactions and the regulation of testis function. Ann. N. Y. Acad. Sci. 637, 354-363.
113. Song, N., Liu, J., An, S., Nishino, T., Hishikawa, Y., and Koji, T. (2011). Immunohistochemical analysis of histone H3 modifications in germ cells during mouse spermatogenesis. Acta Histochem. Cytochem. 44, 183-190.
114. Song, R., Hennig, G. W., Wu, Q., Jose, C., Zheng, H., and Yan, W. (2011). Male germ cells express abundant endogenous siRNAs. Proc. Natl. Acad. Sci. U.S.A. 108, 13159-13164.
115. Sonne, S. B., Kristensen, D. M., Novotny, G. W., Olesen, I. A., Nielsen, J. E., Skakkebaek, N. E., et al. (2008). Testicular dysgenesis syndrome and the origin of carcinoma in situ testis. Int. J. Androl. 31, 275-287.
116. Steilmann, C., Paradowska, A., Bartkuhn, M., Vieweg, M., Schuppe, H.-C., Bergmann, M., et al. (2011). Presence of histone H3 acetylated at lysine 9 in male germ cells and its distribution pattern in the genome of human spermatozoa. Reprod. Fertil. Dev. 23, 997-1011.
117. Suh, N., and Blelloch, R. (2011). Small RNAs in early mammalian development: from gametes to gastrulation. Development 138, 1653-1661.
118. Sultan, C., Lumbroso, S., Poujol, N., Belon, C., Boudon, C., and Lobaccaro, J. M. (1993). Mutations of androgen receptor gene in androgen insensitivity syndromes. J. Steroid Biochem. Mol. Biol. 46, 519-530.
119. Summersgill, B., Goker, H., Weber-Hall, S., Huddart, R., Horwich, A., and Shipley, J. (1998). Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change. Br. J. Cancer 77, 305-313.
120. Suzuki, Y., Yoshinaga, J., Mizumoto, Y., Serizawa, S., and Shiraishi, H. (2012). Foet al exposure to phthalate esters and anogenital distance in male newborns. Int. J. Androl. 35, 236-244.
121. Tachibana, M., Nozaki, M., Takeda, N., and Shinkai, Y (2007). Functional dynamics of H3K9 methylation during meiotic prophase progression. EMBO J.26, 3346-3359.
122. Tong, M.-H., Mitchell, D. A., McGowan, S. D., Evanoff, R., and Griswold, M. D. (2012). Two miRNA clusters, Mir-17-92 (Mirc1) andMir-106b-25 (Mirc3), are involved in the regulation of spermatogonial differentiation in mice. Biol. Reprod. 86, 72.
123. Toppari, J., Kaleva, M., Virtanen, H. E., Main, K. M., and Skakkebaek, N. E. (2007). Luteinizing hormone in testicular descent. Mol. Cell. Endocrinol. 269, 34-37.
124. Toppari, J., Virtanen, H. E., Main, K. M., and Skakkebaek, N. E. (2010). Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res. A Clin. Mol. Teratol. 88, 910-919.
125. Townsend, J. S., Richardson, L. C., and German, R. R. (2010). Incidence of testicular cancer in the United States, 1999-2004. Am. J. Mens Health 4, 353-360.
126. Turnbull, C., and Rahman, N. (2011). Genomewide association studies provide new insights into the genetic basis of testicular germ-cell tumour. Int. I Androl. 34(Pt 2), e86^96.
127. Ugwumba, F. O., and Aghaji, A. E. (2010). Testicular cancer: management challenges in an African developing country. S. Afr. Med. J. 100, 452-455.
128. Umeh, K., and Chadwick, R. (2010). Early detection of testicular cancer: revisiting the role of self-efficacy in testicular self-examination among young asymptomatic males. J. Behav. Med. doi: 10.1007/s10865-010-9262-z [Epub ahead of print].
129. van de Geijn, G.-J. M., Hersmus, R., andLooijenga, L. H. J. (2009). Recent developments in testicular germ cell tumor research. Birth Defects Res. C Embryo Today 87, 96-113.
130. Vanparys, C., Hectors, T. L. M., Blust, R., and De Coen, W. (2012). Mechanistic profiling of the cAMP-dependent steroidogenic pathway in the H295R endocrine disrupter screening system: new endpoints for toxicity testing. Toxicol. Lett. 208, 174-184.
131. Verhoeven, G. (1992). Local control systems within the testis. Baillieres Clin. Endocrinol. Metab. 6, 313-333.
132. Verhoeven, G., Willems, A., Denolet, E., Swinnen, J. V., and De Gendt, K. (2010). Androgens and spermatogenesis: lessons from transgenic mouse models. Philos. Trans. R. Soc. Lond. B Biol. Sci. 365, 1537-1556.
133. Volle, D. H., Decourteix, M., Garo, E., McNeilly, J., Fenichel, P., Auwerx, J., et al. (2009). The orphan nuclear receptor small heterodimer partner mediates male infertility induced by diethylstilbestrol in mice. J. Clin. Invest. 119, 3752-3764.
134. Volle, D. H., Duggavathi, R., Magnier, B. C., Houten, S. M., Cummins, C. L., Lobaccaro, J.-M. A., et al. (2007). The small heterodimer partner is a gonadal gatekeeper of sexual maturation in male mice. Genes Dev. 21, 303-315.
135. Walsh, T. J., Dall'Era, M. A., Croughan, M. S., Carroll, P. R., and Turek, P. J. (2007). Prepubertal orchiopexy for cryptorchidism maybe associated with lower risk of testicular cancer. J. Urol. 178(Pt 1), 1440-1446.
136. Wang, J., Lu, F., Ren, Q., Sun, H., Xu, Z., Lan, R., et al. (2011). Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. Cancer Res. 71, 7238-7249.
137. Wang, R.-S., Yeh, S., Tzeng, C.-R., and Chang, C. (2009). Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice. Endocr. Rev. 30, 119-132.
138. Warde, P., Huddart, R., Bolton, D., Heidenreich, A., Gilligan, T., and Fossa, S. (2011). Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009. Urology 78(Suppl.), S435-S443.
139. Webster, K. E., O'Bryan, M. K., Fletcher, S., Crewther, P. E., Aapola, U., Craig, J., et al. (2005). Meiotic and epigenetic defects in Dnmt3L-knockout mouse spermatogenesis. Proc. Natl. Acad. Sci. U.S.A. 102, 4068-4073.
140. Western, P. (2009). Foet al germ cells: striking the balance between pluripotency and differentiation. Int. J. Dev. Biol. 53, 393-409.
141. Woodruff, T. J. (2011). Bridging epidemiology and model organisms to increase understanding of endocrine disrupting chemicals and human health effects. J. Steroid Biochem. Mol. Biol. 127, 108-117.
142. Wu, J., Bao, J., Wang, L., Hu, Y., and Xu, C. (2011). MicroRNA-184 downregulates nuclear receptor corepressor 2 in mouse spermatogenesis. BMCDev. Biol. 11, 64. doi: 10.1186/1471-213X-11-64
143. Wu, Q., Song, R., Ortogero, N., Zheng, H., Evanoff, R., Small, C. L., et al. (2012). The RNase III enzyme DROSHA is essential for microRNA production and spermatogenesis. J. Biol. Chem. 287, 25173-25190.
144. Yamada, S., Kohu, K., Ishii, T., Ishidoya, S., Ishidoya, S., Hiramatsu, M., et al. (2004). Gene expression profiling identifies a set of transcripts that are up-regulated inhuman testicular seminoma. DNA Res. 11, 335-344.
145. Yaman, R., and Grandjean, V (2006). Timing of entry of meiosis depends on a mark generated by DNA methyl -transferase 3a in testis. Mol. Reprod. Dev. 73, 390-397.
146. Zhou, Y., Zha, J., Xu, Y., Lei, B., and Wang, Z. (2012). Occurrences of six steroid estrogens from different effluents in Beijing, China. Environ. Monit. Assess. 184, 1719-1729.
147. Ziglioli, F., Maestroni, U., Dinale, F., Ciuffreda, M., and Cortellini, R (2011). Carcinoma in situ (CIS) of the testis. Acta Biomed. 82, 162-169.